Therapeutic mechanisms of glucocorticoids

J Vandewalle, A Luypaert, K De Bosscher… - Trends in Endocrinology & …, 2018 - cell.com
Glucocorticoids (GCs) have been used clinically for decades as potent anti-inflammatory
and immunosuppressive agents. Nevertheless, their use is severely hampered by the risk of …

Targeting the transferrin receptor for brain drug delivery

KB Johnsen, A Burkhart, LB Thomsen… - Progress in …, 2019 - Elsevier
Obtaining efficient drug delivery to the brain remains the biggest challenge for the
development of therapeutics to treat diseases of the central nervous system. The main …

Nanotechnology: a promising approach for delivery of neuroprotective drugs

S Naqvi, A Panghal, SJS Flora - Frontiers in Neuroscience, 2020 - frontiersin.org
Central nervous system (CNS) disorders especially neurodegenerative disorders are the
major challenge for public health and demand the great attention of researchers to protect …

Macrophages in heterotopic ossification: from mechanisms to therapy

Y Huang, X Wang, D Zhou, W Zhou, F Dai… - NPJ Regenerative …, 2021 - nature.com
Heterotopic ossification (HO) is the formation of extraskeletal bone in non-osseous tissues. It
is caused by an injury that stimulates abnormal tissue healing and regeneration, and …

Nanotechnology: intelligent design to treat complex disease

P Couvreur, C Vauthier - Pharmaceutical research, 2006 - Springer
The purpose of this expert review is to discuss the impact of nanotechnology in the treatment
of the major health threats including cancer, infections, metabolic diseases, autoimmune …

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis …

R Gold, C Linington, H Lassmann - Brain, 2006 - academic.oup.com
In view of disease heterogeneity of multiple sclerosis and limited access to ex vivo
specimens, different approaches must be undertaken to better understand disease …

Nanoparticles in modern medicine: state of the art and future challenges

SK Murthy - International journal of nanomedicine, 2007 - Taylor & Francis
Nanoparticles are materials with overall dimensions in the nanoscale, ie, under 100 nm. In
recent years, these materials have emerged as important players in modern medicine, with …

Genomic and nongenomic effects of glucocorticoids

C Stahn, F Buttgereit - Nature clinical practice Rheumatology, 2008 - nature.com
The strong anti-inflammatory and immunosuppressive effects of glucocorticoids are
mediated primarily by the cytosolic glucocorticoid receptors. These receptors are members …

Nanoscale drug delivery systems and the blood–brain barrier

R Alyautdin, I Khalin, MI Nafeeza… - International journal …, 2014 - Taylor & Francis
The protective properties of the blood–brain barrier (BBB) are conferred by the intricate
architecture of its endothelium coupled with multiple specific transport systems expressed on …

Getting into the brain: approaches to enhance brain drug delivery

MM Patel, BR Goyal, SV Bhadada, JS Bhatt, AF Amin - CNS drugs, 2009 - Springer
Being the most delicate organ of the body, the brain is protected against potentially toxic
substances by the blood-brain barrier (BBB), which restricts the entry of most …